Meningitis: Bacterial, Viral, and Other


Bacterial Meningitis

Definition

Meningitis is an inflammation of the arachnoid membrane, the pia mater, and the intervening cerebrospinal fluid (CSF). The inflammatory process extends throughout the subarachnoid space around the brain and spinal cord and involves the ventricles. Pyogenic meningitis is usually an acute bacterial infection that evokes a polymorphonuclear response in CSF. By comparison, tuberculous meningitis ( Chapter 299 ) is often subacute and characterized initially by a modest polymorphonuclear pleocytosis that rapidly evolves to lymphocytic predominance.

Epidemiology

The incidence of bacterial meningitis has dropped dramatically to about 0.5 to 1.5 cases per 100,000 adults in developed countries largely because of vaccines against bacterial pathogens such as Haemophilus influenzae type b ( Chapter 274 ), Streptococcus pneumoniae ( Chapter 268 ), and Neisseria meningitidis ( Chapter 306 ). Since the advent of the Haemophilus vaccine, S. pneumoniae has become the most common pathogen, accounting for about 70% of cases, and the disease is now more common in older adults than children. Unfortunately, mortality rates (~15%) have not changed. Worldwide, the incidence of bacterial meningitis is related to poverty and remains a major cause of mortality (over 230,000 deaths annually ) and morbidity. Although all human microbes have the potential to cause meningitis, only a few organisms cause most cases of bacterial meningitis.

The clinical setting in which meningitis develops may provide a clue to the specific bacterial cause. H. influenzae ( Chapter 277 ) affects primarily children, whereas S. pneumoniae ( Chapter 268 ) affects predominantly adults older than age 50 years with comorbid conditions. Meningococcal meningitis ( Chapter 274 ) often occurs in outbreaks. In developed countries, Listeria monocytogenes ( Chapter 272 ) is emerging as the most common cause of bacterial meningitis, with peak frequencies in neonates and in persons older than 60 years of age. Simultaneous mixed bacterial meningitis is rare but may occur after neurosurgical procedures, penetrating head injury, head trauma with fracture of the cribriform plate, erosion of the skull or vertebrae by adjacent neoplasm, extension of osteomyelitis, or intraventricular rupture of a cerebral abscess. Isolation of anaerobes should strongly suggest the latter two of these situations. In approximately 10% of patients with pyogenic meningitis, the bacterial cause cannot be defined.

Over the past several decades, gram-negative bacillary meningitis has doubled in frequency in adults, a change reflecting more frequent and extensive neurosurgical procedures, as well as other nosocomial factors. L. monocytogenes ( Chapter 272 ) has increased 8- to 10-fold as a cause of bacterial meningitis. Listeria infections are often food-borne via dairy products, processed meats, uncooked vegetables, and pre-cut salads. Although Listeria meningitis may occur in immunocompetent individuals, it occurs most frequently in individuals who are immunocompromised owing to organ transplantation, hemodialysis, corticosteroid therapy, chemotherapy for cancer or autoimmune diseases, liver disease, alcoholism, uncontrolled diabetes, and pregnancy. Meningitis caused by coagulase-negative staphylococci, which represents approximately 3% of cases in large urban hospitals, occurs as a complication of neurosurgical procedures and is often caused by methicillin-resistant strains.

In large tertiary care hospitals, approximately 40% of cases of bacterial meningitis in adults are of nosocomial origin. The leading causes are gram-negative bacilli (primarily Escherichia coli and Klebsiella ), which account for approximately 40% of nosocomial episodes, as well as various streptococci, Staphylococcus aureus , and coagulase-negative staphylococci, each responsible for approximately 10% of nosocomial cases.

Meningococcal disease ( Chapter 274 ), including meningitis, may occur sporadically and in cyclic outbreaks. High-risk groups include individuals who live in close quarters such as crowded classrooms, college dormitories, military barracks, or jails. It is carried in the nasopharynx and spread by nasal or oral secretions. With the introduction of the meningococcal vaccine, the incidence of meningococcal meningitis has decreased dramatically, although vaccinated populations remain vulnerable to the serotypes that are not covered by the vaccine. Antibiotic-resistant strains of meningococcus also have emerged.

Predisposing factors for the development of pneumococcal meningitis include acute otitis media ( Chapters 268 and 394 ), with or without mastoiditis, in approximately 20% of adult patients. Pneumonia is present in approximately 15% of patients with pneumococcal meningitis, a much higher frequency than in meningitis caused by H. influenzae or N. meningitidis . Acute pneumococcal sinusitis ( Chapter 394 ) is occasionally the initial focus from which infection spreads to the meninges. A recent or remote major head injury ( Chapter 368 ) precedes approximately 10% of episodes of pneumococcal meningitis, and CSF rhinorrhea (usually caused by a fracture in the cribriform plate) is present in approximately 5% of patients. Occasionally, meningitis caused by S. pneumoniae develops in patients with central nervous system (CNS) shunts. Splenectomy or splenic dysfunction, as in sickle cell anemia ( Chapter 149 ), cirrhosis ( Chapter 139 ) with portal hypertension, or defects in humoral immunity also predispose patients to pneumococcal meningitis. Alcoholism ( Chapter 364 ) is an underlying risk factor in 10 to 25% of adults with pneumococcal meningitis in urban hospitals.

The estimated annual incidence of bacterial meningitis (primarily pneumococcal) in untreated patients infected with human immunodeficiency virus (HIV; Chapter 353 ) and untreated with antiretrovirals is 150-fold higher than in the general population. However, cryptococcal meningitis and tuberculous meningitis are much more common in HIV-infected patients.

S. aureus ( Chapter 267 ) meningitis may occur from a neurosurgical procedure, after penetrating skull trauma, or occasionally with staphylococcal bacteremia, and methicillin-resistant forms are increasing in frequency. Meningitis caused by group A streptococci is uncommon but occasionally occurs after acute otitis media, more often in children than in adults.

Meningitis caused by gram-negative bacilli takes one of two forms in adults: meningitis after trauma or neurosurgery (e.g., shunt infections), or spontaneous meningitis in adults (e.g., bacteremic Klebsiella meningitis in a patient with diabetes mellitus, sinusitis, or otitis media). The most common causes of gram-negative bacillary meningitis in adults are E. coli (≈30%) and Klebsiella-Enterobacter (≈40%), but Bacteroides ( Chapter 273 ), Fusobacterium ( Chapter 273 ), Clostridioides ( Chapter 271 ), Actinomyces ( Chapter 304 ), and Propionibacterium ( Chapter 272 ) species also can cause meningitis. H. influenzae type b meningitis in an adult suggests an underlying anatomic or immunologic defect.

Pathobiology

Pathology

On gross examination, purulent exudate in the subarachnoid space is most abundant in the cisterns at the base of the brain and over the convexities of the Rolandic and Sylvian sulci, which are expansions of the subarachnoid space. Although neither the infecting organism nor the inflammatory exudate directly invades cerebral tissue, the subjacent brain becomes congested and edematous. The pial barrier generally prevents bacterial meningitis from causing a cerebral abscess; when these two processes coexist, the sequence is usually that an initial abscess leaks its contents into the ventricular system or the subarachnoid space, where it produces secondary ventriculitis and/or meningitis.

The inflammatory exudate can extend around the perivascular spaces to adjacent structures, especially the arteries and veins that carry a layer of pia mater and arachnoid membrane as they enter the brain from the cortical surface. Cortical thrombophlebitis results from venous stasis and adjacent meningeal inflammation. Infarction of cerebral tissue may follow. Involvement of cortical and pial arteries by peripheral aneurysm formation and vascular occlusion or narrowing (related to spasm, arteritis, or both) of the supraclinoid portion of the internal carotid artery at the base of the brain occurs in approximately 15% of patients with meningitis. The anterior and middle cerebral arteries may also develop stenosis or spasm. In fulminating cases, particularly meningococcal meningitis, cerebral edema may be marked even though the pleocytosis is only moderate. Rarely, temporal lobe herniation through the tentorium develops in such patients and compresses the midbrain, thereby leading to ipsilateral third nerve palsy and contralateral hemiparesis; or cerebellar herniation through the foramen magnum with compression of the medulla, which results in apnea, hemodynamic instability, and coma. Damage to cranial nerves occurs in areas where dense exudate accumulates around the nerves; the third and sixth cranial nerves are also vulnerable to damage by increased intracranial pressure. Ventriculitis accompanies most cases of bacterial meningitis and may rarely progress to ventricular empyema . As the exudates accumulate, obstruction of the flow of CSF may result in hydrocephalus . Obstruction of the cerebral aqueduct or foramina of Magendie and Luschka at the base of the fourth ventricle results in noncommunicating or obstructive hydrocephalus, whereas obstruction at the level of the arachnoid granulations in the venous sinuses results in communicating hydrocephalus. Subdural effusions are sterile transudates that develop over the cerebral cortex and can be demonstrated readily by computed tomography (CT) as low-density areas about the cerebrum. On magnetic resonance imaging (MRI), they appear as high signal intensity lesions of T2 or fluid-attenuated inversion recovery (FLAIR) sequences. Rarely, such an effusion becomes an infected subdural empyema.

Pathogenesis

Bacteria may gain access to the meninges by several routes: (1) hematogenous spread from a distant site; (2) direct ingress from the upper respiratory tract or skin through an anatomic defect (e.g., skull fracture, meningocele, sequela of surgery); (3) passage intracranially through venules in the nasopharynx; or (4) spread from a contiguous focus of infection (infection of the paranasal sinuses, leakage of a brain abscess). Bacteremic spread of H. influenzae, N. meningitidis , and S. pneumoniae is probably the most frequent path of infection. Bacteremia is usually initiated by pharyngeal adhesion and colonization by an infecting strain. Adhesion of such strains, as well as of S. pneumoniae , to mucosal surfaces is abetted by their capacity to produce proteases that cleave immunoglobulin A, thus inactivating this local antibody defense. Adhesion of N. meningitidis to nasopharyngeal cells is affected by fimbriae or pili and promoted by previous damage to ciliated cells such as from smoking or viral infections. Meningococci invade the nasopharyngeal mucosal cells by means of endocytosis and are transported to the abluminal side in membrane-bound vacuoles. H. influenzae , in contrast, invades intercellularly by causing separation of the apical tight junctions between columnar epithelial cells. When these meningeal pathogens gain access to the blood stream, their intravascular survival is aided by the presence of polysaccharide capsules that inhibit phagocytosis and confer resistance to complement-mediated bactericidal activity.

Bacteria also may travel along nerve tracts to invade the brain. For example, L. monocytogenes invades the intestine, and animal models suggest that these bacteria can travel along the vagus nerve to the brain stem, from where they also may invade the meninges in the posterior fossa.

Bacteria can gain access to the subarachnoid spaces from blood cells, either by disruption of the blood-brain barrier or via the choroid plexus, also termed the blood-CSF barrier. Once established in any part of the meninges, infection quickly extends throughout the subarachnoid space. Bacterial replication proceeds relatively unhindered because the low CSF levels of immunoglobulin and complement early in meningeal inflammation result in minimal or no opsonic or bactericidal activity and because surface phagocytosis of unopsonized organisms is meager in such a fluid environment. During meningitis, the concentrations of immunoglobulins in CSF increase but still remain relatively low. Secondary bacteremia may follow meningeal infection and may itself contribute to continuing further inoculation of CSF.

Bacterial meningitis following head trauma occurs because of a dural fistula from the nasal cavity, paranasal sinuses, or middle ear to the subarachnoid space. The most frequent site is at the cribriform plate, where the bone is thin and the dura is tightly adherent to the bone. Leakage of CSF results in CSF rhinorrhea and loss of smell.

Cerebral blood flow, which depends on mean arterial pressure, is increased in the early stages of meningitis, but it subsequently decreases, substantially in some patients, which may cause ischemic neurologic injury. Localized regions of marked hypoperfusion, attributable to focal vascular inflammation or thrombosis, can occur in patients with normal blood flow. Impairment of cerebral blood flow autoregulation, as measured by transcranial Doppler ultrasonography of the middle cerebral artery, occurs early in acute bacterial meningitis and causes cerebral blood flow to correspond directly to mean arterial blood pressure, with attendant hyperperfusion or hypoperfusion of the brain. On recovery, the ability of the cerebral vasculature to maintain a constant level of perfusion despite variations in mean arterial pressure is restored.

Genetics

Patients with defects in cell-mediated immunity are susceptible to the development of CNS infections with intracellular organisms such as L. monocytogenes . Patients with defective humoral immunity and an inadequate antibody response are particularly vulnerable to meningitis with S. pneumoniae and H. influenzae . For example, deficiencies in the complement system predispose patients to meningitis, and 50 to 60% of adults with pneumococcal meningitis may have C2 deficiency. Mutation in the intron of UBE2U, which is involved in antigen presentation, is also linked to severity of pneumococcal meningitis. Meningococcal meningitis is associated with polymorphisms in CD32, CD16, mannose-binding lectin, toll-like receptor 4 (TLR4), and the B-2 adrenoceptor gene. Patients with neutropenia are at higher risk for meningitis with Pseudomonas aeruginosa and members of the Enterobacteriaceae family.

Clinical Manifestations

History

Acute-onset fever, generalized headache, vomiting, and stiff neck are common to many types of meningitis ( Table 381-1 ). Most patients with community-acquired pyogenic meningitis have had an antecedent or accompanying upper respiratory tract infection or nonspecific febrile illness, acute otitis (or mastoiditis), or pneumonia. Myalgia, particularly in patients with meningococcal disease, backache, and generalized weakness are common symptoms. The illness usually progresses rapidly, with the development of confusion, obtundation, and loss of consciousness. Occasionally, the onset may be less acute, with meningeal signs being present for several days to a week.

TABLE 381-1
SYMPTOMS AND SIGNS OF BACTERIAL MENINGITIS
CHARACTERISTIC EPISODES OF MENINGITIS
Duration of symptoms <24 hr
  • 48%

Predisposing conditions

  • Otitis or sinusitis

  • Pneumonia

  • Immunocompromise

  • 25%

  • 12%

  • 16%

Symptoms at initial evaluation

  • Headache

  • Nausea

  • Neck stiffness

  • 87%

  • 74%

  • 83%

Triad of fever, neck stiffness, and change in mental status
  • 44%

Focal neurologic deficits
  • 33%

Aphasia
  • 23%

Hemiparesis
  • 7%

Indices of CSF inflammation
Opening pressure (mm H 2 O) 370 ± 130
White cell count §
Mean (cells/µL) 7753 ± 14,736
<100/µL 7%
100-999/µL 14%
>999/µL 78%
Protein (g/L) 4.9 ± 4.5
CSF/blood glucose ratio 0.2 ± 0.2
Positive blood culture
  • 66%

Blood tests

  • 46 ± 37

  • 225 ± 132

  • 198,000 ± 100,000

CSF = cerebrospinal fluid; ESR = erythrocyte sedimentation rate.

Data from 696 cases reported in van de Beek D, de Gans J, Spanjaard L, et al. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med . 2004;351:1849-1859. The study included 671 patients who had a total of 696 episodes of community-acquired meningitis. Plus-minus values are means ± standard deviation.

Immunocompromise was defined by the use of immunosuppressive drugs, a history of splenectomy, or the presence of diabetes mellitus or alcoholism, as well as patients infected with human immunodeficiency virus.

CSF pressure was measured in 216 patients.

§ The CSF leukocyte count was determined in 659 patients; CSF specimens from 14 patients had too many leukocytes for an exact count to be performed.

Blood culture was performed in 611 patients.

The ESR was determined in 549 patients.

∗∗ C-reactive protein levels were determined in 394 patients.

†† The thrombocyte count was determined in 653 patients.

General Physical Findings

Evidence of meningeal irritation is usually present, as evidenced by a stiff neck, Kernig sign (inability to straighten the leg when the hip is flexed to 90 degrees), and Brudzinski sign (involuntary flexion of the hip and knee when the neck is passively flexed). Neck stiffness, Kernig sign, and Brudzinski sign each have sensitivities of approximately 30% or lower for diagnosing acute bacterial meningitis in adults. Although the classic triad of fever, stiff neck, and change in mental status is initially present in only about 45% of episodes, a combination of two of four symptoms (headache, fever, stiff neck, and altered mental status) is found in 95% of patients. The findings of meningitis may be easily overlooked in infants, obtunded patients, elderly patients with heart failure or pneumonia, or immunosuppressed individuals, who may have meningitis without prominent meningeal signs; in such patients, lethargy should be investigated carefully, meningeal signs should be sought, and examination of CSF is indicated if any doubt exists. In elderly patients, neck stiffness may be difficult to evaluate because of osteoarthritis in the neck or stiffness of neck muscles secondary to basal ganglia disorders. When neck stiffness is caused by meningitis, the neck resists flexion but can be rotated passively from side to side; with cervical spine disease, however, resistance is present in all directions of neck movement. Neck stiffness disappears during coma.

The presence of a petechial or ecchymotic rash (see Fig. 274-2 in Chapter 274 ) in a patient with meningeal findings almost always indicates meningococcal infection and requires prompt treatment because of the rapidity with which this infection can progress ( Chapter 274 ). Rarely, extensive petechial and ecchymotic lesions occur in meningitis caused by S. pneumoniae, H. influenzae , or echovirus type 9. Very rarely, skin lesions almost indistinguishable from those of meningococcal bacteremia occur in patients who have acute S. aureus endocarditis (see Fig. 61-1 in Chapter 61 ) and who also have meningeal signs and pleocytosis (secondary to either staphylococcal meningitis or embolic cerebral infarction). Usually, one or two of the lesions in such a patient represent purulent purpura; aspiration of material reveals staphylococci on Gram staining. In the summer, viral aseptic meningitis may produce meningeal signs, macular and petechial skin lesions, and a pleocytosis of several hundred cells, sometimes with neutrophils predominating initially.

Fulminant meningococcal septicemia may cause hemorrhages within the adrenal glands and result in Waterhouse-Friderichsen syndrome ( Chapter 208 ), a condition characterized by the sudden onset of a febrile illness, large petechial hemorrhages in the mucous membranes and skin, cardiovascular collapse, and disseminated intravascular coagulation. In contrast, hyponatremia and the syndrome of inappropriate secretion of antidiuretic hormone may develop in patients with meningitis attributable to H. influenzae . A concurrent respiratory tract infection or acute otitis media may be present with either H. influenzae or S. pneumoniae .

In patients with a basilar skull fracture, the potential for development of a dural fistula and bacterial meningitis is indicated by the presence of CSF rhinorrhea, periorbital ecchymoses, bruising behind the ear (Battle sign), hemotympanum, or blood in the external auditory canal. Meningitis complicating neurosurgical procedures may be insidious in onset and difficult to distinguish from the altered consciousness and signs of meningeal irritation that are expected in the postoperative period. However, fever or prolonged obtundation is an indication for evaluation of CSF.

Neurologic Findings and Complications

Neurologic abnormalities in patients with inadequately treated bacterial meningitis can be severe and disabling. Cranial nerve abnormalities, involving principally the third, fourth, sixth, or seventh nerve, occur in 5 to 10% of adults with community-acquired meningitis and usually disappear shortly after recovery. The most likely sites of involvement in patients with persistent sensorineural deafness appear to be the inner ear (infection or toxic products possibly spreading from the subarachnoid space along the cochlear aqueduct) and the acoustic nerve.

Seizures (focal or generalized; Chapter 372 ) occur in 20 to 30% of patients and may result from reversible causes (high fever or hypoglycemia in infants, penicillin neurotoxicity when large doses are administered intravenously [IV] to patients with renal failure) or, more commonly, from focal cerebral injury related to arterial hypoperfusion and infarction, cortical venous thrombosis, or focal edema and cerebritis. Seizures can occur during the first few days or can appear with associated focal neurologic deficits caused by vascular inflammation some days after onset of the meningitis. In adults with seizures accompanying meningitis, S. pneumoniae is more commonly the cause, but alcohol withdrawal is a confounding factor.

Increased CSF pressure, which can be caused by brain swelling or hydrocephalus, is associated with seizures, vomiting, sixth and third nerve dysfunction, abnormal reflexes, reduced consciousness or coma, dilated and poorly reactive pupils, and the Cushing response of decerebrate posturing, hypertension, bradycardia, and irregular respirations. In approximately a fourth of fatal cases of community-acquired meningitis in adults, cerebral edema accompanied by temporal lobe herniation is observed at autopsy.

Papilledema (see Fig. 391-25 in Chapter 391 ) occurs in less than 1% of patients with bacterial meningitis, even with high CSF pressure, probably because the patient is seen early in the process before changes in the nerve head have occurred. The presence of this sign should indicate the possibility of another associated or independent suppurative intracranial process, such as subdural empyema or brain abscess or a more chronic process such as fungal or tuberculous meningitis. Marked central hyperpnea sometimes occurs in patients with severe bacterial meningitis; CSF acidosis, which is principally due to increased lactic acid levels, provides much of the respiratory stimulus.

Focal cerebral signs (principally hemiparesis, dysphasia, visual field defects, and gaze preference) occur in approximately a third of adults with community-acquired bacterial meningitis. These signs may develop because of arterial or venous occlusion or concurrent development of brain abscess ( Chapter 382 ), subdural empyema or cerebral edema. In addition, cerebral blood flow velocity may be decreased in patients with increased intracranial pressure and may lead to temporary or lasting neurologic dysfunction. It is important to distinguish these vascular effects from postictal changes (Todd paralysis), which usually persist for less than a day. Meningitis may cause the syndrome of inappropriate secretion of antidiuretic hormone.

Diagnosis

Bacterial meningitis is a medical emergency that requires immediate diagnosis and rapid institution of antimicrobial therapy. Delay in treatment is the most critical factor in determining the morbidity and mortality of patients with bacterial meningitis. The diagnosis of bacterial meningitis is not difficult in a febrile patient with meningeal symptoms and signs developing in the setting of a predisposing illness. The diagnosis may be less obvious in an elderly, obtunded patient with pneumonia or a confused alcoholic patient in impending delirium tremens.

When the diagnosis of bacterial meningitis is entertained, blood cultures should be performed, CSF examined and cultured and antimicrobial therapy instituted promptly. Observational data suggest that the prompt performance of a lumbar puncture before CT scanning is associated with significantly earlier treatment and favorable outcomes. If a mass lesion (cerebral abscess, subdural empyema) is suspected from the history (e.g., recent seizure), clinical setting (e.g., coma), or physical findings (e.g., papilledema, focal cerebral signs, decorticate or decerebrate posturing, abnormal breathing pattern, or fixed or dilated pupils), CT with or without contrast enhancement or MRI should be performed because of the danger of brain herniation with lumbar puncture.

Antibiotics can and should be started immediately, with the goal of a door to antibiotics time of less than 1 hour, even before performing lumbar puncture, because it takes approximately 2 hours for antibiotics to affect CSF cultures. Empiric corticosteroids (see Treatment) also should be given at this same time. Diagnostic lumbar puncture should not be delayed to perform CT or MRI except in patients who have focal neurologic findings suggestive of a parameningeal collection or other intracranial mass lesions; in such patients, it is critical to initiate antimicrobial therapy for meningitis of unknown origin or brain abscess before CT or MRI is performed. Patients with community-acquired meningitis rarely have important abnormalities detected on CT in the absence of focal neurologic findings.

Laboratory Findings

Cerebrospinal Fluid Examination

Initial CSF pressure is usually moderately elevated (200 to 300 mm H 2 O in adults). Striking elevations (≥450 mm H 2 O) occur in occasional patients with acute brain swelling complicating meningitis in the absence of an associated mass lesion. Findings on CSF analysis are strikingly abnormal in patients with meningitis, and such findings help suggest the cause even before the results of culture are available ( Table 381-2 ). In patients with skull fractures, CSF rhinorrhea can be distinguished from nasal secretions by the presence of glucose.

TABLE 381-2
COMMON CEREBROSPINAL FLUID FINDINGS IN PATIENTS WITH MENINGITIS
Modified from Kim KS. Acute bacterial meningitis in infants and children. Lancet Infect Dis . 2010;10:32-42.
MICROORGANISM CSF OPENING PRESSURE (cm H 2 O) CELL COUNT (CELLS/µL) PROTEIN (mg/dL) GLUCOSE (mg/dL)
Normal 10-20 <5 20-40 40-60
Bacteria >20 >1000 >100 <10
Mycobacterium tuberculosis >20 100-500 >100 10-45
Borrelia burgdorferi <20 100-500 50-150 10-45
Treponema pallidum <20 5-500 50-150 10-45
Fungi <20 5-500 >100 10-45
Viruses <20 5-500 50-150 Normal
Ranges of biochemical tests may vary in different laboratories.
CSF = cerebrospinal fluid.

Group B streptococci, Escherichia coli, Listeria monocytogenes, Streptococcus pneumoniae, Neisseria meningitidis , and Haemophilus influenzae type b.

Gram-Stained Smear

By the time of hospitalization, most patients with pyogenic meningitis have large numbers (≥10 5 /mL) of bacteria in their CSF. Careful examination of the Gram-stained smear of the spun sediment of CSF reveals the etiologic agent in 60 to 80% of cases. In most instances in which gram-positive diplococci (or short-chain cocci) are observed on a stained CSF smear, they are pneumococci. Enterococcus , an occasional cause of nosocomial meningitis, is detected by latex particle agglutination. Rarely, three species may morphologically mimic Neisseria in CSF or may suggest a mixed infection with short gram-negative rods and meningococci: Acinetobacter baumannii, Moraxella sp, and Pasteurella multocida .

Rapid Bacteriologic Diagnosis

Broad-range polymerase chain reaction (PCR) testing, which can be performed on CSF within 1.5 hours, can diagnose bacterial meningitis in patients in whom cultures will be negative. Overall reported sensitivities in various studies range from 87 to 100%, with specificities of 98 to 100%. PCR also can rapidly diagnose viral meningitis, which overall is far more common than bacterial meningitis, thereby establishing an alternative diagnosis so that antibiotics can be discontinued because a combined viral and bacterial meningitis is highly unlikely. However, because a totally negative PCR result does not exclude bacterial meningitis, other tests (cell count; glucose, protein, and lactic acid levels), which served as proxies while awaiting culture results in an earlier era, still remain very useful in such patients. Metagenomic testing or DNA sequencing also may be useful for diagnosing rare organisms. In resource-poor countries, a urine reagent strip that detects cells, proteins, and glucose in CSF has a sensitivity of 92% and a specificity of 98% for diagnosing bacterial meningitis. Such an approach may be especially useful for distinguishing bacterial meningitis from cerebral malaria ( Chapter 316 ).

Culture of CSF reveals the etiologic agent in 80 to 90% of patients with bacterial meningitis if CSF is obtained before or within 1 to 2 hours of the initiation of antibiotics, but its sensitivities decline to less than 50% with longer delays. For therapeutic decisions, a positive PCR or a positive culture mandates a full course of antibiotic treatment.

Cell Count

Cell counts should be determined promptly because the cells will begin to lyse after 90 minutes. The normal CSF white blood cell count is less than 5/µL (all mononuclear). The cell count in untreated meningitis usually ranges between 100 and 10,000/µL, with polymorphonuclear leukocytes predominating initially (>80%) and lymphocytes appearing subsequently.

Extremely high cell counts (>50,000/µL) should raise the possibility of intraventricular rupture of a cerebral abscess. Cell counts as low as 10 to 20/µL may be observed early in bacterial meningitis, particularly that caused by N. meningitidis and H. influenzae . Occasionally, in granulocytopenic patients or in elderly persons with overwhelming pneumococcal meningitis, CSF may contain very few leukocytes and yet may appear grossly turbid because of the presence of a myriad of organisms and an elevated protein level. Meningitis caused by several bacterial species ( Mycobacterium tuberculosis, Borrelia burgdorferi, Treponema pallidum, Leptospira sp, Francisella tularensis, Brucella sp) is characteristically associated with a lymphocytic pleocytosis. L. monocytogenes meningitis usually elicits a polymorphonuclear response, but rarely lymphocytes may predominate.

Glucose

CSF glucose is reduced to values of 40 mg/dL or less (or <50% of the simultaneous blood level) in 50% of patients with bacterial meningitis; this finding helps distinguish bacterial meningitis from most viral meningitides or parameningeal infections. However, a normal CSF glucose value does not exclude the diagnosis of bacterial meningitis. The blood glucose level should be determined simultaneously because patients with diabetes mellitus (or those who are receiving intravenous glucose infusions) have an elevated CSF glucose level that can be appreciated only by comparison with the simultaneous blood level; however, it may take 90 to 120 minutes for equilibration to occur after major shifts in the level of glucose in the circulation.

Protein

The level of protein in lumbar CSF is usually elevated to greater than 100 mg/dL, and higher values are more commonly observed in pneumococcal meningitis. Extreme elevations, 1000 mg/dL or greater, may indicate subarachnoid block with obstruction of CSF flow. Values higher than 15 mg/dL in ventricular CSF are considered abnormal. If the lumbar puncture is traumatic, the CSF protein level is corrected by subtracting 1 mg/dL for every 1000 red blood cells.

Lactic Acid

Elevated levels of lactic acid occur in pyogenic meningitis. The diagnostic accuracy of a CSF lactate level is at least as good as a cell count for differentiating bacterial from aseptic meningitis; a value above 3.0 mmol/L has a sensitivity and specificity of 94 to 95% for bacterial meningitis. However, the CSF lactate level is less useful in patients who have received antibiotics, and it also may be increased in other conditions such as cerebral ischemia, stroke, and head trauma.

Blood and Respiratory Tract Cultures

Bacteremia is demonstrable in approximately 80% of patients with H. influenzae meningitis, 50% of patients with pneumococcal meningitis, and 30 to 40% of patients with meningococcal meningitis. Hence, blood cultures should be performed routinely in patients suspected of having bacterial meningitis. Cultures of the upper respiratory tract are not helpful in establishing an etiologic diagnosis.

Determination of serum creatinine and electrolyte levels is important in view of the gravity of the illness, the occurrence of specific abnormalities secondary to the meningitis (syndrome of inappropriate secretion of antidiuretic hormone), and problems with therapy in patients with renal dysfunction (seizures and hyperkalemia with high-dose penicillin therapy). In patients with extensive petechial and purpuric skin lesions, evaluation for coagulopathy is indicated.

Radiologic Studies

Because of the frequency with which pyogenic meningitis is associated with primary foci of infection in the chest, nasal sinuses, or mastoid, radiographs of these areas should be taken when clinically indicated at the appropriate time after antimicrobial therapy is begun. Initial head CT or MRI is not indicated in most patients with bacterial meningitis. For example, in patients who undergo head CT or MRI before lumbar puncture for suspected meningitis, only approximately 5% have a mass effect identified on CT. Baseline clinical features associated with abnormal findings on CT include age older than 60 years, history of CNS disease, seizure within the previous week, abnormal level of consciousness, abnormal visual fields, limb drift, and aphasia. In patients without any of these clinical findings, only approximately 1% have a mass effect identified on CT or MRI that would raise concern regarding lumbar puncture.

Specific changes that may be observed on CT or MRI during meningitis include cerebral edema and enlargement of the subarachnoid spaces, contrast enhancement of the leptomeninges and the ependyma, or patchy areas of diminished density as a result of associated cerebritis and necrosis. In patients with meningitis whose clinical status deteriorates or fails to improve, CT or MRI may help demonstrate suspected complications—that is, sterile subdural collections or empyema; ventricular enlargement secondary to communicating or obstructive hydrocephalus; prominent persisting basilar meningitis; extensive areas of cerebral infarction resulting from occlusion of major cerebral arteries, veins, or venous sinuses; or marked ventricular wall enhancement suggesting ventriculitis or ventricular empyema. MRI is superior to CT for visualizing these abnormalities. Rarely, cerebral hemorrhage identifiable on CT may complicate acute bacterial meningitis in adults. In approximately 10% of adults with bacterial meningitis, findings on cranial CT (mastoid or sinus wall defect, eroding retrobulbar mass, pneumocephalus) are indicative of disruption of the dural barrier.

Rarely, paraparesis or tetraparesis resulting from myelitis may complicate bacterial meningitis. In this situation, T2-weighted or short tau inversion recovery (STIR) sequences on MRI can be helpful to exclude spinal cord compression by an extramedullary mass.

Differential Diagnosis

Headache, fever, stiff neck, confusion, vomiting, and pleocytosis are features of meningeal inflammation and are common to many types of meningitis (e.g., bacterial, fungal, viral, chemical) and also some parameningeal processes. The CSF findings are most helpful in distinguishing among these processes ( Chapters 382 and 383 ), and PCR can usually provide a rapid diagnosis.

In most modern studies of adults, viral meningitis or encephalitis is about four times more common than bacterial meningitis ( Table 381-3 ). Although a lymphocyte-predominant pleocytosis without hypoglycorrhachia is characteristic of viral (usually enteroviral or herpes simplex virus type 2 [HSV-2]) meningitis or meningoencephalitis (HSV-1), the initial CSF finding may be a polymorphonuclear response (of ≤60%) that quickly becomes mononuclear. HSV-1 encephalitis is suggested by neurologic findings (dysphasia, hemiparesis, olfactory hallucinations, other temporal lobe signs, seizures), abnormalities in the orbitofrontal and medial temporal lobes on MRI, and distinctive electroencephalographic changes in the temporal lobe or lobes.

TABLE 381-3
CAUSES OF NON-NOSOCOMIAL MENINGITIS AND ENCEPHALITIS IN U.S. ADULTS
Hasbun R, Rosenthal N, Balada-Llasat JM, et al. Epidemiology of meningitis and encephalitis in the United States, 2011-2014. Clin Infect Dis . 2017;65:359-363.
Enterovirus 51%
Unknown cause 19%
Bacterial 14%
Herpes simplex 8%
Noninfectious 3%
Fungal 3%
Other viruses 2%

The rash, fever, and headache of Rocky Mountain spotted fever ( Chapter 302 ) may suggest meningococcal infection, but the geographic and seasonal predilections of the former can provide clues. Approximately 10% of patients hospitalized with Rocky Mountain spotted fever have CSF cell counts higher than 100/µL (>70% polymorphonuclear), and thus the condition initially may be confused with bacterial meningitis. The rash associated with enteroviral infections typically consists of erythematous macules and papules on the face, neck, and trunk.

Acute subarachnoid hemorrhage ( Chapter 377 ) may be confused with bacterial meningitis because of headache, stiff neck, and vomiting. However, subarachnoid hemorrhage usually has a more abrupt onset without a prodromal fever but with evidence of subarachnoid blood on CT or CSF examination. In patients with neuroleptic malignant syndrome ( Chapters 379 and 386 ), fever, generalized rigidity, and a fluctuating level of consciousness with autonomic instability and leukocytosis may develop. The most specific laboratory abnormality in these patients is a markedly elevated creatine kinase level.

In patients who have meningitis but whose CSF does not reveal the etiologic agent on a Gram-stained smear or PCR test, particularly when the CSF glucose level is normal and the polymorphonuclear pleocytosis is atypical, certain treatable processes that can mimic bacterial meningitis should be considered in the differential diagnosis:

  • 1.

    Parameningeal infections . The presence of infections (chronic ear or nasal accessory sinus infections, lung abscess) predisposing to brain abscess ( Chapter 382 ), epidural (cerebral or spinal) abscess, subdural empyema, or pyogenic venous sinus phlebitis should be considered ( Chapter 382 ). Neurologic symptoms may appear in the course of primary bacterial meningitis, but their presence may indicate the presence of a space-occupying infectious process in the CNS. Neurologic symptoms or findings antedating the onset of meningeal symptoms may suggest a parameningeal infection. Isolation of an anaerobic organism should suggest the possibility of intraventricular leakage of a cerebral abscess.

  • 2.

    Bacterial endocarditis . Bacterial meningitis may occur during bacterial endocarditis ( Chapter 61 ) caused by pyogenic organisms such as S. aureus and enterococci. In subacute bacterial endocarditis, sterile embolic infarctions of the brain may produce meningeal signs and a pleocytosis consisting of several hundred cells, including polymorphonuclear leukocytes. A history of dental manipulation, fever, and anorexia antedating the meningitis should be sought; careful examination for heart murmurs and peripheral stigmata of endocarditis is indicated.

  • 3.

    “Chemical” meningitis . The clinical and CSF findings (polymorphonuclear pleocytosis and even reduced glucose level) of bacterial meningitis may be produced by chemically induced inflammation. Acute meningitis after diagnostic lumbar puncture or spinal anesthesia may result from bacterial or chemical contamination of equipment or anesthetic agent. Chemical meningitis, characterized by polymorphonuclear pleocytosis, hypoglycorrhachia, and a latent period of 3 to 24 hours, occurs after 1% of metrizamide myelograms. Endogenous chemical meningitis resulting from material from an epidermoid tumor or a craniopharyngioma leaking into the subarachnoid space, a glioblastoma invading the ventricles ( Chapter 175 ), or carcinomatous meningitis (see later) can produce polymorphonuclear pleocytosis and hypoglycorrhachia.

Treatment

Antimicrobial Agents

Antimicrobial therapy should be initiated promptly in this life-threatening emergency, even before performing an emergent lumbar puncture and within 1 hour of hospital arrival. Subsequent management should be undertaken with close monitoring, often in an intensive care unit. Treatment should be aimed at the most likely causes based on clinical clues, such as the age of the patient, the presence of a petechial or purpuric rash, a recent neurosurgical procedure, and CSF rhinorrhea. If the infecting organism is observed on examination of a Gram-stained smear of the CSF sediment, specific therapy is initiated. If the etiologic agent is not seen on a smear from a patient with suspected bacterial meningitis or if lumbar puncture is delayed because head CT is needed, empirical antimicrobial therapy should be initiated ( Table 381-4 ).

TABLE 381-4
INITIAL EMPIRICAL THERAPY FOR COMMUNITY-ACQUIRED AND NOSOCOMIAL PURULENT MENINGITIS BASED ON AGE AND CLINICAL SETTING (see Table 381-8 FOR DOSING SCHEDULES)
Modified from van de Beek D, Brouder MC, Thwaites GE, et al. Advances in treatment of bacterial meningitis. Lancet . 2012;380:1693-1702.
PREDISPOSITIONS LIKELY PATHOGENS PREFERRED ANTIMICROBIALS ALTERNATIVE ANTIMICROBIALS
Age
<50 yr N. meningitidis, S. pneumoniae Vancomycin plus ceftriaxone or cefotaxime Meropenem (? plus vancomycin )
>50 yr S. pneumoniae, N. meningitidis, L. monocytogenes , aerobic gram-negative bacilli Vancomycin plus ceftriaxone or cefotaxime plus ampicillin Vancomycin plus ceftriaxone or cefotaxime plus trimethoprim-sulfamethoxazole
Impaired immunity L. monocytogenes , gram-negative bacilli, S. pneumoniae, Staphylococcus, Salmonella Ampicillin plus cefepime or meropenem plus vancomycin Trimethoprim-sulfamethoxazole plus meropenem
Cerebrospinal fluid leak or basilar skull fracture S. pneumoniae , various streptococci, H. influenzae Vancomycin plus cefotaxime or ceftriaxone Vancomycin plus meropenem
After neurosurgery or penetrating trauma S. aureus , coagulase-negative staphylococci, aerobic gram-negative bacilli (including P. aeruginosa ) Vancomycin plus cefepime Vancomycin plus ceftazidime or vancomycin plus meropenem
Cerebrospinal fluid shunts (external or internal) Coagulase-negative staphylococci, S. aureus , aerobic gram-negative bacilli (including P. aeruginosa ), Propionibacterium acnes Vancomycin plus cefepime Vancomycin plus ceftazidime or vancomycin plus meropenem

If dexamethasone is also administered, consideration should be given to the addition of rifampin.

Adequate CSF bactericidal activity, which is critical to cure the meningitis, depends on the ability of the antibiotic to penetrate CSF and maintain its activity in the purulent exudate, as well as on its metabolism and rate of clearance from CSF. With the exception of rifampin and chloramphenicol, the commonly used antimicrobial agents do not readily penetrate the normal blood-brain barrier, but the passage of penicillin and other antimicrobial agents is enhanced in the presence of meningeal inflammation ( Table 381-5 ). Antimicrobial drugs should be administered intravenously throughout the treatment period; the dose should not be reduced as the patient improves because normalization of the blood-brain barrier during recovery reduces the achievable CSF drug levels. Bactericidal drugs (penicillin, ampicillin, third-generation cephalosporins) are preferred whenever possible, and CSF levels of antibiotics at least 10 to 20 times the minimal bactericidal concentration are needed for optimal therapy.

TABLE 381-5
PERMEABILITY OF ANTIBIOTICS INTO CEREBROSPINAL FLUID
Courtesy Allen Aksamit, Mayo Clinic, Rochester, MN.
GOOD CONCENTRATIONS IN CSF WITH AND WITHOUT MENINGITIS ADEQUATE CONCENTRATIONS IN CSF IN MENINGITIS FAIR TO POOR CONCENTRATIONS IN CSF IN MENINGITIS
Chloramphenicol
Sulfonamides
Cephalosporins

  • Cefotaxime

  • Ceftriaxone

  • Ceftazidime

  • Moxalactam

  • Cefepime

Metronidazole
Trimethoprim-sulfamethoxazole
Isoniazid
Linezolid
Fluconazole
Fluoroquinolones

  • Penicillin

  • Ampicillin

  • Methicillin

  • Oxacillin

  • Nafcillin

  • Carbenicillin

  • Ticarcillin

  • Tetracycline

  • Erythromycin

  • Ethambutol

  • Rifampin

  • Vancomycin

  • Meropenem

Early cephalosporins

  • Cephalothin

  • Cefoxitin

Aminoglycosides

  • Gentamicin

  • Tobramycin

  • Amikacin

Clindamycin
Benzathine penicillin

CSF = cerebrospinal fluid.

Empiric Treatment

Initial treatment of presumed bacterial meningitis when the etiologic agent cannot be identified on a Gram-stained smear of CSF is based on the available clinical clues. In adults, therapy with vancomycin and a third-generation cephalosporin (cefotaxime or ceftriaxone) is recommended (see Table 381-4 ). In adults older than 50 years and in high-risk groups, ampicillin is also added because of the possibility of the presence of L. monocytogenes , which is susceptible to ampicillin or amoxicillin but not to third-generation cephalosporins. In a penicillin-allergic individual, trimethoprim-sulfamethoxazole is a suitable alternative for Listeria meningitis. In special settings, such as nosocomial meningitis associated with neurosurgical procedures or penetrating head trauma, more resistant species such as methicillin-resistant S. aureus (MRSA), coagulase-negative staphylococci, and P. aeruginosa may be responsible; in these situations, options for initial therapy include vancomycin plus a β-lactam (such as cefepime, ceftazidime, or meropenem). If β-lactams are contraindicated, linezolid, aztreonam, or ciprofloxacin is recommended for gram-negative coverage.

Meningitis of Specific Bacterial Cause

Pneumococcal Meningitis

Antimicrobial susceptibilities should be determined for all pneumococcal isolates from CSF, blood, or sterile body fluids (see Table 381-5 ). If the minimal inhibitory concentration for cefotaxime or ceftriaxone (≤1.0 µg/mL) indicates a susceptible isolate, cefotaxime or ceftriaxone is the drug of choice. If the isolate is highly penicillin resistant or is resistant to 1 µg/mL ceftriaxone or cefotaxime, alternative therapy (vancomycin with or without rifampin IV) is indicated. Because of the increasingly wide distribution of highly resistant strains, initial therapy (pending susceptibility testing) with cefotaxime (or ceftriaxone) in addition to vancomycin IV is recommended. When initial adjunctive therapy with dexamethasone is used (see later) along with vancomycin, CSF vancomycin levels may be reduced by concomitant corticosteroid use.

The β-lactam antibiotic meropenem is as effective as cefotaxime for meningitis caused by S. pneumoniae, N. meningitidis , and H. influenzae . Cefepime is also similar to ceftriaxone and cefotaxime for infection with S. pneumoniae, N. meningitidis , and H. influenzae , and it has greater activity than these antibiotics against Enterobacter sp and P. aeruginosa ( Table 381-6 ).

TABLE 381-6
ANTIMICROBIAL THERAPY FOR COMMUNITY-ACQUIRED BACTERIAL MENINGITIS OF KNOWN CAUSE (SEE TABLE 381-8 FOR DOSING SCHEDULES)
ORGANISM PREFERRED ANTIMICROBIAL THERAPY ALTERNATIVE ANTIMICROBIAL THERAPY
Streptococcus pneumoniae
Penicillin MIC <0.1 µg/mL
Penicillin MIC 0.1-1 µg/mL
Penicillin MIC ≥2.0 µg/mL
Cefotaxime or ceftriaxone MIC ≥1.0 µg/mL
Penicillin G or ampicillin
Ceftriaxone or cefotaxime
Vancomycin (plus cefotaxime or ceftriaxone)
Vancomycin (plus cefotaxime or ceftriaxone)
Cefotaxime, or ceftriaxone, or vancomycin, or chloramphenicol
Vancomycin, or meropenem, or cefepime
Moxifloxacin or gatifloxacin
Moxifloxacin or gatifloxacin
Neisseria meningitidis
Penicillin MIC <0.1 µg/mL
Penicillin MIC 0.1-1.0 µg/mL
Penicillin G or ampicillin
Ceftriaxone or cefotaxime
Ceftriaxone, or cefotaxime, or chloramphenicol
Chloramphenicol, or meropenem, or gatifloxacin, or moxifloxacin
Haemophilus influenza
β-Lactamase negative
β-Lactamase positive
Ampicillin
Ceftriaxone or cefotaxime
Ceftriaxone, or cefotaxime, or cefepime, or chloramphenicol
Cefepime, or chloramphenicol, or gatifloxacin, or moxifloxacin
Listeria monocytogenes Ampicillin or penicillin G (plus vancomycin) Trimethoprim-sulfamethoxazole or meropenem
Streptococcus agalactiae (group B streptococci) Ampicillin or penicillin G Cefotaxime or ceftriaxone
MIC = minimal inhibitory concentration.

Addition of rifampin should be considered. Consider intrathecal (or intraventricular vancomycin, 5 to 20 mg/day) if not responding to intravenous therapy.

Addition of intravenous gentamicin should be considered.

You're Reading a Preview

Become a Clinical Tree membership for Full access and enjoy Unlimited articles

Become membership

If you are a member. Log in here